HAEMOPHILUS SP - ANVISA Registration 80254180479
Access comprehensive regulatory information for HAEMOPHILUS SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180479 and manufactured by manufacturer not specified. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Apr 07, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including programa nacional de controle de qualidade ltda, and 1 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
80254180479
25351448327202495
04930429000139
Company Information
Dates and Status
Apr 07, 2025
07/04/2035
09/18/2025 19:00:01
HAEMOPHILUS SP
Controle Interno Microbiologia - Haemophilus sp
programa nacional de controle de qualidade ltda
80155020048
Feb 17, 2025
STREPTOCOCCUS
Família discos impregnados com agentes antimicrobianos isolados - Streptococcus
OXOID LIMITED
80254180478
Mar 17, 2025
STREPTOCOCCUS
Família discos impregnados com agentes antimicrobianos isolados - Streptococcus
Not specified
80254180478
Mar 17, 2025
DISCS AND TAPES IMPREGNATED WITH ISOLATED OR GROUPED ANTIMICROBIAL AGENTS
FAMÍLIA: DISCOS E FITAS IMPREGNADOS COM AGENTES ANTIMICROBIANOS ISOLADOS OU GRUPOS
LABORCLIN PRODUTOS PARA LABORATORIOS LTDA
10097010128
Aug 11, 2004
DISCS AND TAPES IMPREGNATED WITH ISOLATED OR GROUPED ANTIMICROBIAL AGENTS
FAMILIA DE DISCOS E FITAS IMPREGNADOS COM AGENTES ANTIMICROBIANOS OU GRUPOS
OXOID LIMITED
80254180273
Apr 24, 2017